Shock Syndromes I
Kumar A, Ellis P, Arabi Y, et al. Initiation of inappropri-
ate antimicrobial therapy results in a fivefold reduction of
survival in human septic shock. Chest. 2009;136(5):1237-
1248. https://doi.org/10.1378/chest.09-0087
Kumar A, Roberts D, Wood KE, et al. Duration of
hypotension before initiation of effective antimicrobial
therapy is the critical determinant of survival in human
https://doi.org/10.1097/01.ccm.0000217961.75225.e9
Kumar A, Safdar N, Kethireddy S, Chateau D. A sur-
vival benefit of combination antibiotic therapy for serious
infections associated with sepsis and septic shock is
contingent only on the risk of death: a meta-analytic/
1664. https://doi.org/10.1097/ccm.0b013e3181e96b91
Lamontagne F, Masse MH, Menard J, et al. Intravenous
vitamin C in adults with sepsis in the intensive care
unit. N Engl J Med. 2022;386(25):2387-2398. https://doi.
org/10.1056/nejmoa2200644
Landry DW, Oliver JA. The pathogenesis of vasodilatory
shock. N Engl J Med. 2001;345(8):588-595. https://doi.
org/10.1056/nejmra002709
Leisman D, Huang V, Zhou Q, et al. Delayed second
dose antibiotics for patients admitted from the emer-
gency department with sepsis: prevalence, risk factors,
https://doi.org/10.1097/ccm.0000000000002377
Levy MM, Evans LE, Rhodes A. The Surviving
Med.
2018;46(6):997-1000.
https://doi.org/10.1097/
ccm.0000000000003119
Marik PE. Early management of severe sepsis: concepts
and controversies. Chest. 2014;145(6):1407-1418. https://
doi.org/10.1378/chest.13-2104
Marik PE, Khangoora V, Rivera R, Hooper MH, Catravas
J. Hydrocortisone, vitamin C, and thiamine for the treat-
ment of severe sepsis and septic shock: a retrospective
before-after study. Chest. 2017;151(6):1229-1238. https://
doi.org/10.1016/j.chest.2016.11.036
Meyhoff TS, Hjortrup PB, Wetterslev J, et al. Restriction
of intravenous fluid in ICU patients with septic shock.
N Engl J Med. 2022;386(26):2459-2470. https://doi.
org/10.1056/nejmoa2202707
Meyhoff TS, Møller MH, Hjortrup PB, Cronhjort M,
Perner A, Wetterslev J. Lower vs higher fluid volumes
during initial management of sepsis: a systematic
review with meta-analysis and trial sequential analysis.
Chest. 2020;157(6):1478-1496. https://doi.org/10.1016/j.
chest.2019.11.050
Morelli A, Ertmer C, Rehberg S, et al. Phenylephrine
versus norepinephrine for initial hemodynamic support
of patients with septic shock: a randomized, controlled
cc7121
Moskowitz A, Huang DT, Hou PC, et al. Effect of ascor-
bic acid, corticosteroids, and thiamine on organ injury
in septic shock: the ACTS randomized clinical trial.
jama.2020.11946
Mouncey PR, Osborn TM, Power GS, et al. Trial of early,
goal-directed resuscitation for septic shock. N Engl J
Med. 2015;372(14):1301-1311. https://doi.org/10.1056/
nejmoa1500896
Nagendran M, Russell JA, Walley KR, et al. Vasopressin
in septic shock: an individual patient data meta-anal-
Med.
2019;45(6):844-855.
https://doi.org/10.1007/
s00134-019-05620-2
National Heart, Lung, and Blood Institute Prevention
and Early Treatment of Acute Lung Injury Clinical Trials
Network; Shapiro NI, Douglas IS, Brower RG, et al. Early
restrictive or liberal fluid management for sepsis-induced
hypotension. N Engl J Med. 2023;388(6):499-510. https://
doi.org/10.1056/nejmoa2212663
Ospina-Tascon G, Neves AP, Occhipinti G, et al. Effects
of fluids on microvascular perfusion in patients with
https://doi.org/10.1007/s00134-010-1843-3
Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl
starch 130/0.42 versus Ringer’s acetate in severe sep-
sis. N Engl J Med. 2012;367(2):124-134. https://doi.
org/10.1056/nejmoa1204242
Polito A, Parisini E, Ricci Z, Picardo S, Annane D.
Vasopressin for treatment of vasodilatory shock: an
ESICM systematic review and meta-analysis. Intensive
s00134-011-2407-x
ProCESS Investigators; Yealy DM, Kellum JA, Huang
DT, et al. A randomized trial of protocol-based care for